NewslettersCell Therapy News Allogeneic Hematopoietic Cell Transplant in Patients with Relapsed/Refractory Anaplastic Large Cell Lymphoma By Bob - September 19, 2022 0 Non-relapse mortality, disease relapse/progression, progression-free surviva, and overall survival were modeled using Cox proportional hazards models. [British Journal of Haematology] Abstract